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Abstract
Background: Chronic stress is a major contributor in the development of metabolic syndrome and associated
diseases, such as diabetes. High-fat diet (HFD) and sex are known modifiers of metabolic parameters. Peptide hormones
corticotropin-releasing factor (CRF) and urocortins (UCN) mediate stress responses via activation and feedback to the
hypothalamic-pituitary-adrenal (HPA) axis. UCN3 is a marker of pancreatic β-cell differentiation, and UCN2 is known
to ameliorate glucose levels in mice rendered diabetic with HFD. CRF receptor 2 (CRF2) is the only known cognate
receptor for UCN2/3. Here, we ascertained the role of CRF2 in glucose clearance, insulin sensitivity, and other parameters
associated with metabolic syndrome in a mouse model of nutritional stress.
Methods: Wild-type (WT) and Crhr2−/− (null) mice of both sexes were fed either normal chow diet or HFD.
After 8 weeks, blood glucose levels in response to glucose and insulin challenge were determined. Change in body
and fat mass, plasma insulin, and lipid profile were assessed. Histological evaluation of liver sections was performed.
Results: Here, we show that genotype (Crhr2), sex, and diet were all independent variables in the regulation of blood
glucose levels, body and fat mass gain/redistribution, and insulin resistance. Surprisingly, CRF2-deficient mice (Crhr2
−/−)
male mice showed similarly impaired glucose clearance on HFD and chow. HFD-fed female Crhr2−/− mice redistributed
their fat depots that were distinct from wild-type females and male mice on either diet. Blood cholesterol and low-
density lipoprotein (LDL) levels were elevated significantly in male Crhr2−/− mice; female Crhr2−/− mice were protected.
Male, but not female Crhr2−/− mice developed peripheral insulin resistance. HFD, but not chow-fed wild-type male
mice developed hepatic macrovesicular steatosis. In contrast, livers of Crhr2−/− male mice showed microvesicular
steatosis on either diet, whereas livers of female mice on this 8-week HFD regimen did not develop steatosis.
Conclusions: CRF2 receptor dysregulation is a sexually dimorphic risk factor in development of pre-diabetic and
metabolic symptoms.
Keywords: Blood glucose, Dyslipidemia, Fat mass, Hepatic steatosis, Plasma insulin
Introduction
Stress is a major risk factor in the development of meta-
bolic syndrome and type 2 diabetes [1, 2]. Diabetes is
reaching epidemic proportions with nearly 8.3% of global
population diagnosed as diabetic [3, 4]. Acute stress re-
sponses mobilize body’s energy reserves to cope with the
changed energy requirements in the short-term [5];
however, long-term stress is detrimental to health. Stress
responses are coordinated by the corticotropin-releasing
factor (CRF) family that comprises four known peptide
hormones—CRF and three urocortins (UCN 1–3)—and
two G protein-coupled receptors (GPCRs)—CRF1 and
CRF2 [6]. CRF2 is encoded by the gene Crhr2 present on
chromosome 7 in humans and 6 in mice. CRF is intim-
ately involved in regulation of behavioral and endocrine
stress responses by activating the HPA axis via CRF1.
Urocortins dampen stress sensitivity via activation of the
CRF2. CRF and UCNs are also involved in regulating
cardiovascular function [7, 8] and inflammatory re-
sponses [9–12]. Both UCN2 and UCN3 are known to
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regulate glucose homeostasis in animal models of type 2
diabetes [13, 14]. CRF2 is the main receptor that medi-
ates stress-coping actions of psychological stressors and
downregulation of its expression and function is ob-
served during chronic stress [15].
UCN3 is thought to be a marker for β-cell maturity
and function [14]. UCN3 is stored and released with in-
sulin, participating in a negative feedback loop that pro-
motes somatostatin release to ensure timely reduction of
insulin secretion [14]. Lack of UCN3 has been linked to
excessive insulin release, contributing to the pathophysi-
ology of diabetes [14]. A single intravenous injection of
adeno-associated virus encoding urocortin2 (AAV.UCn2)
normalized blood glucose in db/db and C57BL/6 mice
rendered diabetic with HFD [13]. CRF2 is required to
mediate therapeutic effects of UCN2, and null mice for
CRF2 (Crhr2
−/−) are unable to improve glucose
mobilization even in presence of AAV.UCn2 [13]. Thus,
CRF2 is crucial in mediating effects of UCN2 and prob-
ably UCN3 in glucose homeostasis.
Nutritional excess as seen with intake of calorie-rich
foods, contributes to the development of type 2 diabetes
and metabolic syndrome. Metabolic syndrome refers to a
cluster of abnormalities including impaired glucose
metabolism, insulin sensitivity, obesity, and dyslipidemia
[16–18]. The abnormalities associated with metabolic syn-
drome are risk factors for cardiovascular diseases and dia-
betes. In experimental animal models, excess dietary fat
consumption contributes to impaired glucose metabolism,
leading to development of insulin resistance and hypergly-
cemia [19]. High-fat diet feeding has been used as a model
to induce type 2 diabetes, obesity, and associated pheno-
types in mice [20]. Psychological stressors downregulate
expression of CRF2 receptors [21], and CRF2 receptor null
mice (Crhr2−/−) are more anxious than wild-type litter-
mates [22, 23]. Psychological stressors also drive
sex-specific metabolic disturbances in human population
studies [1], but whether downregulation of CRF2 receptors
also drives metabolic disturbances, such as hyperglycemia,
insulin resistance, dyslipidemia, and fatty liver associated
with nutritional stress, has not been shown. In this study,
we asked if impairment of the CRF2 receptor contributed
to the development of sex-specific metabolic phenotypes
during nutritional stress. To test this hypothesis, we sub-
jected Crhr2−/− and wild-type mice of both sexes to
8 weeks of high-fat diet nutritional stress and evaluated
metabolic outcomes.
Here, we report that Crhr2 null male, but not female
mice develop impaired glucose tolerance on standard
chow. In Crhr2 null male mice, fat redistribution and
dyslipidemia contributed to the development of meta-
bolic phenotype and insulin resistance. High-fat diet
worsened insulin sensitivity in Crhr2 null male mice
alone. Sex, diet, and genotype were all significant
variables in both glucose tolerance and insulin sensitiv-
ity, suggesting that dysregulation of CRF2 receptor, a key
mediator of stress responses, is involved in the develop-
ment of diabetes and metabolic syndrome.
Materials and methods
Animal studies
All animal procedures were approved by the Institutional
Animal Care and Use Committee (IACUC) at the Univer-
sity of California San Francisco and were conducted in ac-
cordance with the National Institutes of Health Guide for
the Care and Use of Laboratory Animals. Generation of
Crhr2−/− (C57BL/6 background) mice has been described
previously [23]. Crhr2+/− x Crhr2+/− (heterozygous) mice
were bred to obtain wild-type (WT), heterozygous
(Crhr2+/−), and knockout (Crhr2−/−) male and female mice
as described previously [24]. Littermates of 8–9 weeks of
age weighing 18–20 g (female mice) and 25–29 g (male
mice) were used in all the studies described. The mice
were housed in a room that was temperature (22–25 °C)
and light controlled (12-h: 12-h light/dark cycle starting at
7 AM). The mice were fed with a standard chow diet con-
sisting of 9% fat (PicoLab mouse Diet 20 #5058, Lab Sup-
ply, Fort Worth, Texas, USA) or high-fat diet (HFD) with
60% kcal fat (Catalog# 12492 Research Diets, NJ USA) for
8 weeks. Mice were group housed with 4–5 mice per cage
and provided with enrichment. The entire experiment was
repeated once (n = 4–5/group/sex) with a total of n = 8–
10/group/sex. At the end of the experiments, mice were
euthanized and blood was collected in heparinized 1-ml
syringe from the inferior vena cava. Various tissues were
collected for analyses.
Body mass/weight
Mice were weighed twice weekly throughout the
duration of the study. Mice were handled consistently by
the same researchers (S.P and S-I.H) to minimize
handling-related stress. Change in body mass gain per
week was calculated by subtracting the baseline value
obtained at the start of the study. Percent (%) change in
body mass for chow- or HFD-fed mice was calculated
using the formula: final weight in g − initial weight in g/
initial weight in g × 100 to allow for comparisons be-
tween all groups.
Food intake
Food intake per cage was calculated by dividing the total
food intake per cage/week by number of mice/cage and
is considered as a good measure of food intake [25].
Since body weight gain showed sexual dimorphism, food
intake per mouse was calculated by dividing food intake
per cage/average body weight of the mice per cage (g/g
bw). Percent (%) difference in food intake was calculated
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using the formula: |V1 −V2|(V1 + V2)2 × 100 to allow
for comparisons between all groups.
Glucose tolerance test (GTT)
WT, Crhr2 heterozygous, and Crhr2 null mice of both
sexes were fed with standard chow or HFD for 8 weeks.
Intraperitoneal glucose tolerance test (IP-GTT) was con-
ducted to assess the disposal of glucose by measuring glu-
cose level after fasting for 14–16 h. The testing was
performed at a fixed time to avoid circadian variations in
blood glucose levels. Per day, maximum of two cages of ei-
ther male or female sex (total of 8–10 mice from two cages)
were used to perform GTT or insulin tolerance test. Mice
were weighed after fasting, and baseline (pre-injection or
time 0 min) level of glucose was measured. Mice were
injected ip with 2 g/kg glucose (Sigma, St. Louis, MO,
USA), and glucose levels were measured at 30, 60, and
120 min. Blood samples were obtained by tail nick, and glu-
cose levels were monitored using the Alpha Trak2 glucose
monitor and strips (Abbotts, USA).
Insulin tolerance test (ITT)
WT, Crhr2 heterozygous, and Crhr2 null mice of both
sexes were fasted for 6 h and body weight was recorded.
Blood sample was collected by tail nick and baseline
(0 min) glucose was measured using the Alpha Trak2
glucose monitor and strips (Abbotts, USA). Mice were
injected ip with 0.375 U/kg human insulin (Novolin,
Novo Nordisk), and glucose levels were measured at 15,
30, 45, and 60 min after insulin injection.
Insulin assay and plasma lipid profile analysis
Blood was collected in heparinized vials for insulin
assay and plasma lipid profile analysis. Plasma insulin
was assayed using kit from Mesoscale diagnostics
(www.mesoscale.com, USA). Cholesterol, triglycerides,
and high-density lipoprotein (HDL) were measured using
the Siemens Advia chemistry analyzer (Siemens Health-
care Diagnostics Inc., USA). LDL was calculated using the
formula: LDL Cholesterol = Total cholesterol − (HDL
Cholesterol + Triglycerides/5).
Histology
Tissues were collected and fixed in 4% paraformaldehyde
for 14–16 h. Tissues were paraffin embedded, and 4–6 μm
sections were cut and stained with hematoxylin-eosin at
the Mouse Histology Core Facility, University of California
San Francisco. Livers from four to five mice/group were
imaged, and six to eight fields/liver were captured. A liver
pathologist (Dr. Aras Mattis, MD, PhD), blind to the treat-
ment groups, helped with analysis of liver sections.
Statistical analysis
We considered genotype, diet, and sex as independent
variables. GTT and ITT data was analyzed using
repeated-measure analysis of variance (ANOVA) followed
by Sidak’s post hoc analysis. For all other outcomes, sig-
nificant main effects of each variable and their interactions
were determined using three-way ANOVA. When signifi-
cant main effects were present, Tukey’s multiple compari-
sons were performed. When comparing two groups,
Student’s t test was used. A p value < 0.05 was considered
significant. All statistical analyses were conducted using
the GraphPad Prism 7.0™ software.
Results
Crhr2-deficient male mice gained more body mass than
Crhr2−/− female mice
Body mass gain is associated with metabolic syndrome
and type 2 diabetes. We determined the contribution of
CRF2 receptor (genotype) and sex on body mass gain and
food intake. Genotype, sex, and diet were significant inde-
pendent variables for body weight mass gain and also
showed significant interactions (Fig. 1 and Additional file 1).
At the end of 8 weeks, WT male mice gained ~ 10% body
mass on chow and ~ 47% on HFD (Fig. 1a, c). Crhr2−/−
male mice gained ~ 21% body mass on chow and ~ 53%
on HFD (Fig. 1b, c). WT female mice gained ~ 20% body
mass on chow and ~ 43.6% on HFD (Fig. 1d, f ). Crhr2−/−
female mice gained only ~ 10% body mass on chow
~ 41% on HFD (Fig. 1e, f ), and the body mass gain
between chow and HFD in WT and Crhr2−/− female
mice was not statistically significant. Crhr2+/− male
and female mice also showed significant body mass
gain as compared with their chow-fed controls
(Additional file 1).
Crhr2-deficient male mice increased chow intake, whereas
Crhr2-deficient female mice decreased HFD intake
Genotype, sex, and diet showed significant interaction for
food intake (Fig. 2). Male Crhr2−/− mice increased chow in-
take by 25.71 and 36.89% compared with WTand Crhr2+/−
mice (p = 0.0342 and p = 0.0013 respectively, Fig. 2a and
Additional file 2). No significant difference in HFD intake
in male mice was noted (Fig. 2a). In contrast to male mice,
chow intake in female of different genotypes did not differ,
whereas female Crhr2−/− consumed 44.67% less HFD com-
pared with WT female mice (p = 0.0004, Fig. 2b).
Crhr2 genotype affected blood glucose levels in a sexually
dimorphic manner
To determine the contribution of CRF2 receptor and sex
in glucose clearance, we performed GTT and ITT at the
end of 8 weeks. Genotype, diet, and sex were all vari-
ables in regulation of glucose clearance (Fig. 3). As ex-
pected, HFD-fed WT male mice showed an increase in
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Fig. 1 Crhr2−/− male mice gain more body mass. Line graphs showing weekly change in body mass in a, b male (n = 9/group) and d, e female
(n = 9/group) WT and Crhr2 null mice on chow and HFD. Data is presented as change in body mass per week compared to baseline. c, f Bar
graphs showing percent (%) change in body mass for chow- or HFD-fed mice. Three-way ANOVA and post hoc Tukey’s multiple comparisons.
****p < 0.0001, Crhr2−/− male mice chow vs. HFD and ***p = 0.0005, WT male HFD vs. Crhr2−/− male HFD
Fig. 2 Crhr2−/− male mice increase chow diet intake. Column bar graphs showing weekly average food intake per mouse in g/g body weight. a
Crhr2 null male mice consumed 31.68% more chow per week than WT littermates (p = 0.0342, n = 8/group) (b) WT female mice consumed 27.57%
more HFD per week than Crhr2 null littermates (p = 0.0004, n = 8/group). Three-way ANOVA and post hoc Tukey’s multiple comparisons
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the area under the curve (AUC) compared with
chow-fed controls (Fig. 3a, c). Surprisingly, chow-fed
Crhr2−/− male mice had AUC that was equivalent to that
of HFD-fed Crhr2−/− male mice (Fig. 3b, c). On the
other hand, HFD-fed female WT and Crhr2−/− mice
showed impaired IP-GTT responses with significantly el-
evated blood glucose levels and AUC compared to
chow-fed controls (Fig. 3d–f ). HFD-fed Crhr2+/− (het-
erozygous) male and female mice also showed significant
increases in blood glucose levels and AUC compared to
chow-fed controls (Additional file 3).
Crhr2-deficient male mice exhibited impaired insulin
sensitivity, whereas female mice were protected
Genotype, diet, and sex were all variables in regulation
of insulin sensitivity as evidenced by impaired glucose
clearance after a bolus of insulin injection in ITT
(Fig. 4a–e). WT male mice on chow and HFD similarly
Fig. 3 Crhr2−/− male mice show elevated blood glucose levels on chow. In GTT, blood glucose was measured by tail vein sampling before glucose
administration (baseline; 0 min) and at 30, 60, and 120 min after a bolus of intraperitoneal glucose (2 g/kg) injection. Repeated-measure ANOVA
followed by Sidak’s post hoc test was used to analyze GTT data. a In WT male mice, blood glucose levels were significantly elevated at 30 and 60 min
time points on HFD vs. chow. b In Crhr2+/− male mice, blood glucose levels did not differ between the diets, but significantly changed over time.
c Glucose clearance rate, as reflected by AUC, was significantly elevated in HFD- vs. chow-fed WT male mice, whereas AUC in Crhr2−/− male mice was
comparable on HFD and chow. In female (d) WT and (e) Crhr2−/− HFD-fed mice, significant increases in blood glucose levels were noted at 30 and
60 min post glucose injection. f AUC was higher in HFD-fed vs. chow-fed female mice. (n = 8/group/sex)
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Fig. 4 Crhr2−/− male mice have impaired blood glucose clearance in response to insulin challenge. In ITT, blood glucose levels were measured
by tail-vein sampling before (baseline; 0 min) and at 15, 30, 45, and 60 min after ip insulin administration in chow- and HFD-fed mice. Repeated-
measure ANOVA followed by Sidak’s post hoc test was used to analyze ITT data. a–c Male WT mice showed normal response to ITT challenge.
HFD-fed Crhr2−/− male mice had higher blood glucose levels at all times examined and a 2-fold higher AUC. d–f Female WT and Crhr2−/− mice
retained normal ITT responses on chow and HFD. n = 8/group/sex. g CRF2 receptor levels were ~ 1.5-fold higher in livers of WT male on HFD vs.
chow. Expression levels were normalized to β-actin, a housekeeping gene. Student’s t test, n = 8/group
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decreased blood glucose levels in ITT (Fig. 4a–c).
HFD-fed Crhr2−/− male mice had significantly elevated
glucose levels compared to chow-fed Crhr2−/− mice at all
time points (Fig. 4b). The AUC was nearly twofold higher
in HFD-fed vs. chow-fed Crhr2−/− male mice (p < 0.0001,
Fig. 4c). Female Crhr2−/− mice and Crhr2+/− mice of both
sexes retained normal glucose responses in ITT (Fig. 4d–f
and Additional file 4). Since liver is a major site of insulin
action that regulates glucose release, next, we examined
whether HFD modulated CRF2 receptor expression in the
livers of WT male mice. CRF2 receptor expression in-
creased by ~ 1.5-fold in the livers of HFD-fed mice com-
pared to chow-fed mice (Fig. 4g). Taken together, these
data highlight the role of stress receptor, CRF2 in mediat-
ing sexually dimorphic peripheral insulin resistance.
Male, but not female mice on HFD have significantly
higher plasma insulin levels
As Crhr2 null mice were insulin resistant, we next
assessed changes in plasma insulin levels in mice of both
sexes in response to HFD consumption. Genotype, sex,
and diet were significant independent variables and also
showed significant interaction (Fig. 5). Plasma insulin
levels were significantly elevated in HFD-fed WT, Crhr2−/
−, and Crhr2+/− male mice compared to their respective
chow-fed controls (Fig. 5a and Additional file 5). HFD in-
take did not significantly alter plasma insulin levels in fe-
male mice of any genotype compared to chow-fed control
mice (Fig. 5b and Additional file 5).
Sex and diet were variables in fat mass gain and/or
redistribution
Visceral fat mass gain and/or fat mass redistribution are
factors that contribute to metabolic disorder and periph-
eral insulin resistance. Changes in four different fat
types—gonadal (epididymal or ovarian), mesenteric, perire-
nal, and brown fats—were examined. Sex and diet were
variables and showed interaction for fat mass gain
(Fig. 6a–h). In male mice, HFD intake did not significantly
change gonadal (epididymal) or brown fat mass in WTand
Crhr2−/− mice compared to their respective chow-fed con-
trols (Fig. 6a, d). There were significant increases in mesen-
teric and perirenal fat mass in HFD-fed WT male mice
compared to chow-fed controls (Fig. 6b, c). Significant
differences in epididymal and perirenal fats were observed
between chow- and HFD-fed Crhr2+/− male mice
(Additional file 6). In female mice, HFD intake in Crhr2−/−
mice resulted in significant fat mass gained in all four types
of fats examined compared with chow controls (Fig. 6e–h).
Crhr2-deficient male mice showed dyslipidemia, but
female mice were protected
Changes in two or more plasma lipid levels (dyslipid-
emia) are associated with diagnosis of metabolic syn-
drome and type 2 diabetes. Plasma lipid panel that
included cholesterol, high-density lipoprotein (HDL),
and triglycerides was determined using mass spectrom-
etry. Low-density lipoprotein (LDL) levels were calcu-
lated as described in methods. Genotype, sex, and diet
were significant independent variables in plasma lipid
levels and also showed significant interaction (Fig. 7).
Cholesterol
In male mice, HFD intake resulted in elevated plasma
cholesterol levels by 37.7% in WT, 50.3% in Crhr2+/−,
and by 40.9% in Crhr2−/− compared with chow-fed con-
trols (Fig. 7a and Additional file 7a). In female mice,
HFD intake did not result in significant increases in
Fig. 5 Male mice have increased plasma insulin levels on HFD. Column graphs showing plasma insulin levels in chow- and HFD-fed male and
female mice. a Significant increases in insulin levels were seen in male WT and Crhr2−/− mice (HFD vs. chow, n = 9/group). b HFD intake did not
significantly increase plasma insulin levels in female WT and Crhr2−/− mice (n = 9/group). Three-way ANOVA and post hoc Tukey’s multiple comparisons
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Fig. 6 (See legend on next page.)
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plasma cholesterol compared with chow fed controls
(Fig. 7b and Additional file 7b).
HDL
In male mice, plasma HDL levels increased by 36.1% in
WT and by 38.3% in Crhr2+/− compared with chow-fed
controls (Fig. 7c and Additional file 7c). In female mice of
all three genotypes, plasma HDL levels showed did not dif-
fer between chow and HFD (Fig. 7d and Additional file 7d).
LDL
In male mice, plasma LDL levels increased by 53.6% in
Crhr2−/− and by 68.0% in Crhr2+/− compared with
chow-fed controls (Fig. 7e and Additional file 7e). Im-
portantly, HFD-fed Crhr2−/− male mice had approxi-
mately twofold higher LDL levels compared with
HFD-fed WT mice (Fig. 7e). In female mice, LDL levels
did not differ between HFD- and chow-fed mice (Fig. 7f
and Additional file 7f).
Triglycerides
In male mice of either genotype, triglyceride levels did
not differ between HFD vs. chow (Fig. 7g). In female
WT and Crhr2−/− mice, triglyceride levels did not differ
between HFD vs. chow (Fig. 7h). Interestingly, triglycer-
ide levels in chow-fed Crhr2+/− female mice were signifi-
cantly higher compared with chow-fed WT and Crhr2−/−
(Additional file 7 h).
Crhr2-deficient male mice develop microvesicular liver
steatosis
Lipid accumulation in the liver is a characteristic of a myr-
iad of diseases such as type 2 diabetes and metabolic syn-
drome. H&E-stained sections revealed macrovesicular
steatosis in livers of HFD-fed WT male compared with
chow-fed controls with fat droplets vacuoles evident (Fig. 8
a, b, arrows). Surprisingly, livers of chow-fed Crhr2−/−
male mice exhibited microvesicular steatosis with swollen
sinusoids evident (Fig. 8c, arrows) and HFD consumption
for 8 weeks did not further worsen liver steatosis in
Crhr2−/− male mice (Fig. 8d). In sharp contrast to male
mice, chow- or HFD-fed female WT or Crhr2−/− mice did
not show any signs of steatosis (Fig. 8e, f ).
Discussion
Chronic stress is known as a factor contributing to the
development of metabolic syndrome, type 2 diabetes,
and many other pathophysiologies. In this study, we re-
port several novel observations; mice lacking the stress
receptor, CRF2, show impaired glucose clearance and
microvesicular liver steatosis on standard chow diet in a
sexually dimorphic manner. Short-term nutritional stress
rendered male mice of Crhr2-deficient genotype insulin
resistant and dyslipidemic, whereas female mice of
Crhr2 genotype were protected, in the time period ex-
amined. CRF2 receptor activation and function is re-
quired for feedback to the HPA axis to bring systems
back to homeostasis after stress responses. CRF2 recep-
tor dysregulation is reported in chronic stress [21, 26].
Prospective cohort studies have shown that perceived
stress increases risk of developing type 2 diabetes in
men, but not in women by approximately twofold and a
1.4 higher odds ratio [1]. Our findings that only male
mice with Crhr2 genotype, but not female mice develop
impaired glucose clearance and other metabolic pheno-
types on short-term nutritional stress, is in agreement
with clinical reports that men are more prone to devel-
oping type 2 diabetes under stressful conditions. Hap-
loinsufficiency of CRF2 may be akin to downregulation
of CRF2 receptor under chronic stress conditions and in-
creasing the risk of developing metabolic syndrome and
type 2 diabetes.
Male and female mice gained body mass differently on
a fat-rich diet. In animal models, male C57BL/6 mice
gain significantly more body and fat mass than female
mice on HFD [26]. We found that lack or haploinsuffi-
ciency of stress receptor, CRF2, rendered male mice even
more prone to body and fat mass gain on a fat-rich diet
than WT male mice, whereas female mice of Crhr2
genotype were less susceptible to fat-rich diet-induced
changes, at least in this short-term nutritional stress
model. Since body mass gain was significantly different
between the genotypes and sexes, fat mass and food in-
take were normalized to body mass. On a standard diet,
Crhr2 null male mice gained ~ 12% more body mass
than WT littermates. The differences in body mass gain
between WT and Crhr2 null male mice could be
accounted for by increased chow diet intake per week
(See figure on previous page.)
Fig. 6 Sex-specific fat mass gain and/or redistribution on chow vs. HFD. Column bar graphs showing fat mass gain over 8 weeks on chow vs.
HFD consumption in male and female mice. Four types of fat mass—gonadal (epididymal/ovarian), mesenteric, perirenal, and brown—were
assessed. a Diet did not change gonadal fat depots in male mice. b HFD-fed WT and Crhr2−/− male mice increased their mesenteric fat depots
by 53.79% and 145.75%, respectively compared with WT chow-fed controls. c HFD-fed WT male mice increased their perirenal fat depots by
32.67% vs. chow. d HFD-fed male Crhr2−/− mice increased their brown fat depots by 253.1% compared with chow-fed WT mice. e HFD-fed
female Crhr2−/− mice gained 103.91% more ovarian fat vs. chow diet. f HFD-fed female Crhr2−/− mice increased their mesenteric fat depots by
38% vs. chow. g HFD-fed female Crhr2−/− mice increased their perirenal fat mass by 140% vs. chow diet and by ~ 59% compared with HFD-fed
WT female mice. h HFD-fed female Crhr2−/− mice increased their brown fat depots by 60.86% vs. chow controls. n = 5/group/sex. Three-way
ANOVA and post hoc Tukey’s multiple comparisons
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over the 8-week period. On a fat-rich diet, Crhr2 null
male mice gained ~ 6% more body mass than WT litter-
mates, but HFD consumption did not differ between the
two genotypes. Female mice of either genotype showed in-
crease in body weight on HFD, but the body mass gains
were not significantly different from that gained on chow,
suggesting that female mice may handle short-term nutri-
tional stress overload better than male mice.
We found genotype and sex as significant modifiers of
the effect of diet for several metabolic outcomes. First,
only male mice of Crhr2 genotype had worse glucose
clearance on standard chow diet. A recent systematic
study that characterized effects of sex and body weight
on metabolic outcomes on a high-fat diet in C57BL/6
mice found that male mice show worse glucose clear-
ance on high-fat diet than female mice [26]. Further-
more, this published study used nearly 300 mice per sex
to characterize metabolic phenotype on breeder’s chow
and HFD to create a reference database [26]. Our sexu-
ally dimorphic metabolic phenotypes in C57BL/6 mice
are in agreement with this reference data bank.
Genotype, diet, and sex also were significant modifiers of
peripheral insulin responses. In insulin tolerance studies,
only male Crhr2 null mice were hyperglycemic on a
fat-rich diet. Blood glucose level remained significantly ele-
vated in HFD-fed Crhr2 null males after insulin injection
and throughout the duration of the experiment (60 min),
whereas glucose levels returned to baseline in HFD-fed
WT male and female mice. We used the lowest possible
insulin dose, as female Crhr2−/− mice did not tolerate
higher doses of insulin, becoming severely hypoglycemic
and had to be given a bolus of glucose. At the end of
8 weeks of fat-rich diet consumption, CRF2 receptor levels
increased in livers of WT mice suggesting diet-induced
compensation of the stress axis. Others have shown that
palatable food intake feeds back to the HPA axis to better
cope with stress responses [27, 28]. A combination of low
dose of insulin used in ITT, increase in CRF2 receptor
levels, and possible association of CRF2 receptor with an-
cillary proteins [29] that may differ between the sexes, may
explain this sexual dimorphism in metabolic responses to
nutritional stress. It might be possible that CRF2 receptor
levels show bimodal responses to nutritional stress, with
levels increasing during short-term, but decreasing with
long-term (> 8 weeks) HFD consumption. Consistent with
this notion, bimodal levels of CRF2 receptors have been
shown in response to acute vs. chronic inflammatory stress
in other experimental animal models [9].
Enhanced release of glucagon, glycogenolysis, and per-
ipheral insulin resistance may explain hyperglycemia in
Crhr2 null mice. Chronic insulin resistance leads to
hyperinsulinemia and resulting inactivation of insulin
signaling pathways [30–32]. In rodent pancreas, paracrine
communication between α- and β-cells resulted in
insulin-inhibiting glucagon release. Selective inactivation of
insulin receptor in pancreatic α-cells is known to upregu-
late glucagon release [33]. Delivery of anti-insulin anti-
bodies in rat pancreas resulted in increased glucagon
release [34]. High blood glucose levels also stimulated glu-
cagon release [35]. Thus, a compromised stress response
as in the Crhr2 null mice might worsen metabolic function
with higher or dysregulated release of glucagon causing im-
paired glucose clearance and insulin resistance. The next
steps would be to determine insulin and glucagon release
from isolated islet cultures from WT and Crhr2−/− mice
exposed to different glucose concentrations. The exact
mechanism of the insulin-induced hyperglycemia observed
in our experimental model is yet to be investigated.
CRF2 receptors are expressed on pancreatic δ-cells and
may be involved in the release of somatostatin as well as
glucagon from δ- and α-cells, respectively. Somatostatin
and glucagon in turn are known regulators of insulin re-
lease from β-cells [36]. Thus, CRF2 receptor dysfunction
may regulate insulin release via inhibiting somatostatin and
glucagon release in a secondary messenger-dependent
manner. We have previously shown that CRF2 receptors
can alter intracellular concentrations of both cAMP and
Ca2+ [29, 37]. We have also shown sexual dimorphism in
Ca2+-dependent signaling in pancreatic acinar cells in mur-
ine model of acute stress [24]. Furthermore, we have
shown that loss of CRF2 receptors downregulated UCN3
expression [12]. Lack of UCN3 in turn might cause exces-
sive insulin release, contributing to the pathophysiology of
diabetes [14].
Fat depots contribute to peripheral insulin resistance.
Male, but not female mice showed increased plasma in-
sulin levels on a fat-rich diet. HFD-fed male mice signifi-
cantly increased mesenteric and perirenal fat mass
depots, but no changes in gonadal or brown fat mass
were observed. HFD-fed WT female mice did not show
(See figure on previous page.)
Fig. 7 Male mice have increased plasma lipid levels. Column bar graphs show plasma lipid profiles in male and female mice. Plasma cholesterol,
HDL, triglycerides, and LDL levels were determined. a HFD-fed male WT and Crhr2−/− mice had 37.7%, and 40.9% higher blood cholesterol levels
vs. chow diet, respectively. b In female WT and Crhr2−/− mice, HFD consumption resulted in smaller, non-significant increases in blood cholesterol
levels vs. chow. c HFD-fed male WT mice had 36.1% higher HDL levels vs. chow. d In female mice, HDL levels did not differ between HFD vs.
chow. e HFD-fed male Crhr2−/− mice had ~ 53.0% higher calculated LDL levels vs. chow-fed Crhr2−/− and HFD-fed WT mice. f In female mice,
diet did not change LDL levels. g, h In male and female mice, diet did not change triglycerides levels. n = 8/group/sex. Three-way ANOVA and
post hoc Tukey’s multiple comparisons
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any significant gain in fat mass, whereas Crhr2 null
female mice showed significant increases in gonadal,
perirenal, and brown fat depots, despite decreasing
their HFD consumption. The increase in gonadal fat
mass may in part explain why Crhr2 null female mice
take longer to conceive than WT females. This obser-
vation is consistent with others who report that
temporary nutritional stress causes infertility in fe-
male mice [38]. Moreover, increase in brown fat
depot may explain why female mice are protected
from fat-rich diet-induced metabolic phenotypes in
this acute period of nutritional stress. Thus, Crhr2
genotype predisposes males and females differently to
body and fat mass gain on a fat-rich diet.
Fig. 8 Male mice show hepatic steatosis. Representative micrographs showing H&E stained liver sections from WT and Crhr2−/− mice of both
sexes. a Normal hepatocyte morphology is evident in chow-fed WT male mice. b Hepatocytes show ballooning with swollen sinusoids (arrows)
and fat droplets (arrowheads) suggesting presence of macrovesicular steatosis in HFD-fed WT male mice. c, d Hepatocytes show ballooning and
microvesicular steatosis in both chow- and HFD-fed Crhr2 null male mice. e, h The livers of WT and Crhr2 null female mice on either diet show
normal hepatocyte morphology and no evidence of steatosis. Scale bars = 50 μm. CV and PV: central and portal veins, respectively; HC: hepatic cords
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Lipid accumulation in livers is another observed
phenotype of metabolic syndrome. Non-alcoholic fatty
liver is more prevalent in men than women and diet
is a known risk factor. Here, we found that Crhr2
genotype is also a sexually dimorphic risk factor for
liver fat accumulation. Male mice with Crhr2 geno-
type showed microvesicular hepatic steatosis on chow
diet as well as on a fatty diet. Insulin resistance has
been shown to cause hepatic steatosis [39] although
the mechanisms remain to be established [40, 41].
Crhr2 null mice were hyperinsulinemic on a fat-rich
diet. Hyperinsulinemia as result of insulin resistance
causes hepatic steatosis and deposition of lipid drop-
lets in liver cells due to “selective insulin resistance”
[42, 43]. In agreement with other studies [26], we also
found that WT C57BL/6 male mice showed macrove-
sicular steatosis on a fatty diet, whereas female WT
and Crhr2 mice did not show any evidence of hepatic
lipid accumulation in this acute phase of fatty diet
consumption.
Blood cholesterol, HDL, and LDL levels are known
to increase on a fatty diet. In rodents, depending
upon several factors, blood triglyceride levels may or
may not change on a fatty diet [26]. In our study,
blood cholesterol and HDL levels increased in Crhr2
null male, WT male, and female mice on HFD com-
pared with chow-fed controls. Crhr2 null male mice
also had elevated calculated LDL levels. Female mice
of Crhr2 genotype were protected from HFD-induced
dyslipidemia.
Fig. 9 Stress receptor CRF2 dysregulation exacerbates metabolic outcomes of acute dietary stress. Acute or short-term fatty food consumption
perturbs function in multiple target organs, including liver, pancreas, and fat depots, collectively, these manifested symptoms constitute
metabolic syndrome and diabetes. One compensatory mechanism is to increase CRF2 receptor expression/function in the liver and other target
tissues in order to bring function back to homeostasis. If stressors are removed, function can return to homeostasis (black arrows), but chronic
stress exposure may ultimately result in frank metabolic syndrome. Dysregulated CRF2 receptor function (as in Crhr2
−/− mice) compromises
metabolic function even in absence of nutritional stress and puts one on a trajectory to develop metabolic syndrome and diabetes, with males at
a greater risk than females. Chronic stress, including consumption of fat- or calorie-rich diets worsens metabolic functions. Thus, CRF2 receptor is
a sexually dimorphic risk factor for development of metabolic syndrome and associated diseases such as type 2 diabetes
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Conclusions
Our study is the first to report that downregulation of
stress receptors, CRF2, drives metabolic disturbances in
response to nutritional stress in a sexually dimorphic
manner. Stress receptor dysfunction resulted in aberrant
glucose clearance, insulin resistance, increased adiposity,
dyslipidemia, and fatty liver in Crhr2−/− male mice. Sex
was a significant variable in several outcomes analyzed in
this study, with female sex being protective for acute nu-
tritional stress that may be explained by reduced fat-rich
diet intake and increased brown fat depots.
Perspectives and significance
Our studies provide insights into how stress that is often
coupled with intake of calorie-rich diet or comfort feed-
ing might contribute to development of metabolic syn-
drome and type 2 diabetes (Fig. 9). Stress does not target
one organ or system, but has pleiotropic effects. CRF2
receptor deficiency compromised function in multiple
organs. CRF2 receptor dysregulation predisposed male
mice that are not obese or overweight, to be at greater
risk for developing collective symptoms associated with
metabolic syndrome and diabetes. Thus, modulation of
stress receptor function in a sex-specific manner may
help with therapeutic targeting of metabolic syndrome
and associated diseases, such as type 2 diabetes.
Additional files
Additional file 1: Crhr2+/− male mice gain more body mass. Line
graphs showing weekly change in body mass in male (n = 9/group) and
female (n = 9/group) Crhr2+/− mice on chow and HFD. Data is presented
as change in body mass per week compared to baseline. (a) Crhr2+/−
male mice gained ~ 18.6% body mass on chow and ~ 45% on HFD. (b):
Bar graphs showing percent (%) change in body mass for chow- or
HFD-fed mice. HFD-fed Crhr2+/− male mice gained ~ 26% more body
mass than chow-fed Crhr2+/− mice. (c) Crhr2+/− female mice gained ~ 8.8%
body mass on chow and nearly ~ 50.5% on HFD. (d) HFD-fed Crhr2+/−
female mice gained ~ 41.7% more body mass than chow-fed Crhr2+/− mice.
3-Way ANOVA and post hoc Tukey’s multiple comparisons as described in
main text and figure legends. (DOCX 224 kb)
Additional file 2: Weekly food intake in mice. Column bar graphs
showing weekly average food intake per mouse in g/ g body weight. (a)
Crhr2−/− mice increased chow intake by 25.71% and 36.89% compared
with WT and Crhr2+/− mice (n = 8/group) (b) WT female mice consumed
27.57% more HFD per week than Crhr2 null littermates (n = 8/group).
3-Way ANOVA and post hoc Tukey’s multiple comparisons. (DOCX 183 kb)
Additional file 3: Crhr2+/− male mice have elevated baseline blood
glucose levels. In GTT, blood glucose was measured by tail vein sampling
before glucose administration (baseline; 0 min) and at 30, 60, and 120 min
after a bolus of intraperitoneal glucose (2 g/kg) injection. Repeated-measure
ANOVA followed by Sidak’s post hoc test was used to analyze GTT data. (a)
In Crhr2+/− male mice, blood glucose levels were significantly elevated at 0,
30 and 60 min time points on HFD vs. chow. Glucose clearance rate, as
reflected by AUC, was not significantly different on HFD- vs. chow. (b) In
female Crhr2+/− HFD-fed mice, significant increases in blood glucose levels
were noted at 30 only post glucose injection and AUC was higher in
HFD-fed vs. chow-fed female mice. (n = 8/group/sex). (DOCX 259 kb)
Additional file 4: Blood glucose levels in response to insulin challenge
in Crhr2+/− mice. In ITT, blood glucose levels were measured by tail-vein
sampling before (baseline; 0 min) and at 15, 30, 45, and 60 min after ip
insulin administration in chow- and HFD-fed mice. Repeated-measure
ANOVA followed by Sidak’s post hoc test was used to analyze ITT data.
(a-b) Male and female Crhr2+/− mice retained normal ITT responses on
chow and HFD. n = 8/group/sex. (DOCX 282 kb)
Additional file 5: Male mice have increased plasma insulin levels on
HFD. Column graphs showing plasma insulin levels in chow- and
HFD-fed male and female mice. (a) Significant increases in insulin levels
were seen in male WT, Crhr2−/−, and Crhr2+/− mice (HFD vs. chow, n = 9/
group). (b) HFD intake did not significantly increase plasma insulin levels
in female WT, Crhr2−/−, and Crhr2+/− mice (n = 9/group). Three-way
ANOVA and post hoc Tukey’s multiple comparisons. (DOCX 310 kb)
Additional file 6: Sex-specific fat mass gain and/or redistribution on
chow vs. HFD. Column bar graphs showing fat mass gain over 8 weeks
on chow vs. HFD consumption in male and female mice. Four types of
fat mass—gonadal (epididymal/ovarian), mesenteric, perirenal, and
brown—were assessed. (a) Diet did not change gonadal fat depots in
WT and Crhr2−/− male mice, whereas Crhr2+/− mice gained 75.72% more
epididymal fat vs. chow. (b) HFD-fed WT and Crhr2−/− male mice increased
their mesenteric fat depots by 53.79% and 145.75%, respectively compared
with WT chow-fed controls, whereas Crhr2+/− mice showed non-significant
increases in mesenteric fat depots vs. chow. (c) HFD-fed WT male mice
increased their perirenal fat depots by 32.67% and male Crhr2+/− mice
gained 70.68% more perirenal fat mass vs. chow. (d) HFD-fed male Crhr2−/−
mice increased their brown fat depots by 253.1% compared with chow-fed
WT mice. (e) HFD-fed female Crhr2−/− mice gained 103.91% more ovarian
fat vs. chow diet. Female Crhr2+/− mice did not show any significant change
in fat mass on HFD compared with any other group. (f) HFD-fed female
Crhr2−/− mice increased their mesenteric fat depots by 38% vs. chow. (g)
HFD-fed female Crhr2−/− mice increased their perirenal fat mass by 140% vs.
chow diet and by ~ 59% compared with HFD-fed WT female mice. (h)
HFD-fed female Crhr2−/− mice increased their brown fat depots by 60.86%
vs. chow controls. n = 5/group/sex. Three-way ANOVA and post hoc Tukey’s
multiple comparisons. (DOCX 530 kb)
Additional file 7: Male mice have increased plasma lipid levels. Column
bar graphs showing plasma lipid profiles in male and female mice. Plasma
cholesterol, HDL, triglycerides, and LDL levels were determined. (a) HFD-fed
male WT mice had 37.7%, Crhr2+/− mice had 50.3%, and Crhr2−/− mice had
40.9% higher blood cholesterol levels vs. chow diet. (b) In female WT,
Crhr2+/−, and Crhr2−/− mice, HFD consumption resulted in smaller,
non-significant increases in blood cholesterol levels vs. chow. (c) HFD-fed
male WT mice had 36.1% higher and Crhr2+/− had 38.3% higher HDL levels
vs. chow. (d) In female mice, HDL levels did not differ between HFD vs.
chow. (e) HFD-fed male Crhr2−/− mice had ~ 53.0% higher calculated LDL
levels vs. chow-fed Crhr2−/− and HFD-fed WT mice, whereas Crhr2+/− had
68.0% higher LDL vs. chow. (f) In female mice, diet did not change LDL
levels. (g) In male mice, diet did not change triglycerides levels. (h) Female
Crhr2+/− mice had significantly elevated triglyceride levels on both chow
and HFD compared with WT and Crhr2−/− female mice on chow and on
HFD vs. WT chow. n = 8/group/sex. 3-Way ANOVA and post hoc Tukey’s
multiple comparisons. (DOCX 524 kb)
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